FDA recall D-1156-2016

Cantrell Drug Company · Class I · drug

Product

fentaNYL citrate in 0.9% Sodium Chloride Injection, 5 mcg/1 mL (5 mcg/mL), in a) 1 mL syringe (NDC 52533-214-45, UPC: 0100352533214455) and b) 3 mL syringe (NDC 52533-214-60, UPC: 0100352533214608), Rx Only, Cantrell Drug Co., Little Rock, AR

Reason for recall

Subpotent Drug

Distribution

Nationwide

Key facts

Status
Terminated
Initiation date
2015-08-21
Report date
2016-07-13
Termination date
2017-02-03
Voluntary/Mandated
Voluntary: Firm initiated
Location
Little Rock, AR, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1156-2016